Shiran Tehila Mashiah

Shiran Tehila Mashiah serves as the Principal of Pharma and Biotech at Peregrine Ventures, a venture capital firm dedicated to early-stage healthcare investments. In this capacity, she specializes in identifying, evaluating, and managing global private life science opportunities within the pharmaceutical and biotechnology sectors. She works alongside the firm's co-founders and managing general partners, Eyal Lifschitz and Boaz Lifschitz, to source and execute strategic investments across the healthcare landscape. Her investment mandate centers on early-stage enterprises that are developing novel therapeutics, advanced medical technologies, and clinical treatments for unmet medical needs. As a venture capital professional, she leverages her sector expertise to guide portfolio companies through the complex development phases of the life sciences industry. Mashiah currently focuses on deploying capital into emerging life sciences startups to support the clinical advancement of new pharmaceutical and biotechnological solutions.